Polysaccharide Capsule Serotype and Antibiotic Susceptibility Pattern of Streptococcus pneumoniae Clinical Isolates in Bali
Downloads
Streptococcus pneumoniae (S. pneumoniae) is a causative agent of pneumonia that can spread progressively, cause invasive disease, and increase mortality in humans. Pneumococcal or polysaccharide conjugate vaccination reduces pneumonia rates by vaccine-covered serotypes, but increases infection by non-vaccine serotypes. To determine the polysaccharide capsule serotype of S. pneumoniae isolates that cause infection at Prof. Dr. I.G.N.G. Ngoerah General Hospital and patterns of S. pneumoniae susceptibility to antibiotics from April 2017 to March 2022. All S. pneumoniae isolates from April 2017 and April 2022 were stored in STGG media in a freezer at -80 ℃ then subcultured on sheep blood agar. Polymerase Chain Reaction (PCR) was performed to determine pneumolysin and capsular polysaccharide serotypes of S. pneumoniae. Of the 22 isolates studied, the order of the number of serotypes from the highest was serotype 19F, 3, 6A/B, 33F, 15B/C, 4, and 6V. Seven isolates were untypeable. Antibiotic sensitivity pattern S. pneumoniae was found to be sensitive to linezolid 91%, vancomycin 86%, levofloxacin and benzylpenicillin 82%, ceftriaxone and clindamycin 73%, erythromycin 55%, and chloramphenicol 45%. Serotype 19F was identified as the most dominant capsular serotype; however, serotypes 33F and 15B/C were also found. Interestingly, the 33F serotype is not covered in the 13-valent pneumococcal conjugate vaccine (PCV13) but is covered in pneumococcal polysaccharide vaccine 23 (PPSV23), and the 15B/C serotype is not included in either PCV13 or PPSV23. The antimicrobial susceptibility patterns revealed that S. pneumoniae was susceptible to linezolid, vancomycin, benzylpenicillin, and levofloxacin.
Orihuela C. Capsule protects against intracellular killing and enables vascular endothelial cell translocation during invasive pneumococcal disease. 2021;
Gonzales-Siles L, Salví -Serra F, Degerman A, Nordén R, Lindh M, Skovbjerg S, et al. Identification and capsular serotype sequetyping of Streptococcus pneumoniae strains. J Med Microbiol. 2019;68(8):1173–88.
Abdallah FE, Fathy M, Fouda E, Fahmy H, Abdallah N. Antibiotic susceptibility and capsular genes of Streptococcus pneumoniae colonizing children with chronic respiratory diseases. Microbes and Infectious Diseases. 2021;0(0):0–0.
Paton JC, Trappetti C. Streptococcus pneumoniae Capsular Polysaccharide . Microbiol Spectr. 2019;7(2):304–15.
Hadinegoro SR, Prayitno A, Khoeri MM, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children under ï¬ve years old in Central
Lombok Regency, Indonesia. Southeast Asian J Trop Med Public Health. 2016;47:485–93.
Safari D, Harimurti K, Khoeri MM, Waslia L, Mudaliana S, A'yun HQ, et al. Staphylococcus aureus and Streptococcus pneumoniae prevalence among elderly adults in Jakarta, Indonesia. Southeast Asian Journal of Tropical Medicine and Public Health. 2015;46(3):465–71.
Farida H, Severin JA, Gasem MH, Keuter M, Wahyono H, Van Den Broek P, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in pneumonia-prone age groups in Semarang, Java Island, Indonesia. PLoS One. 2014;9(1):16–8.
Fatmawati NND, Tarini NMA, Mayura IPB. Multiplex Pcr For Detection Of Capsular Polysaccharides Types Of Streptococcus pneumoniae Clinical Isolates In Bali. International Journal of Bioscience and Biotechology. 2015;II(2):93–9.
Seftiani F, Saputri D, Wathoni N. Analisis Efektivitas Biaya Penggunaan Vaksin Pneumonia Di Berbagai Negara. Vol. 18. 2020. Available from: https://jurnal.unpad.ac.id/farmaka/article/view/22281/pdf
Amari S, Warda K, Elkamouni Y, Arsalane L, Bouskraoui M. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children with acute otitis media in Marrakech, Morocco [Internet]. Vol. 14. 2022. Available from: http://ijm.tums.ac.ir
Sings HL, De Wals P, Gessner BD, Isturiz R, Laferriere C, Mclaughlin JM, et al. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine against Invasive Disease Caused by Serotype 3 in Children: A Systematic Review and Meta-analysis of Observational Studies. Vol. 68, Clinical Infectious Diseases. Oxford University Press; 2019. p. 2135–43.
Lawrence H, Pick H, Baskaran V, Daniel P, Rodrigo C, Ashton D, et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study. PLoS Med. 2020 Oct 23;17(10).
Matanock A, Lee ; Grace, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Morbidity and Mortality Weekly Report Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices [Internet]. 2019. Available from: https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6846a5-H.pdf
Chen T ming, Li W hui, Wang F, Tan K, Zhu Q xiong, Zhou K, et al. Antibiotics prescription for targeted therapy of pediatric invasive pneumococcal diseases in China: a multicenter retrospective study. BMC Infect Dis. 2021 Dec 1;21(1).
Mohanty S, Johnson KD, Yu KC, Watts JA, Gupta V. A Multicenter Evaluation of Trends in Antimicrobial Resistance Among Streptococcus pneumoniae Isolates From Adults in the United States. Open Forum Infect Dis [Internet]. 2022;9(9):1–9. Available from: https://doi.org/10.1093/ofid/ofac420
Muneer B. Screening of Pneumococcal Pneumonia by Amplification of Pneumolysin Gene in Children Visiting Hospitals in Lahore, Pakistan [Internet]. 2012. Available from: https://www.researchgate.net/publication/235691319
Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44(1):124–31.
Zhao W, Pan F, Wang B, Wang C, Sun Y, Zhang T, et al. Epidemiology characteristics of Streptococcus pneumoniae from children with pneumonia in shanghai: A retrospective study. Front Cell Infect Microbiol. 2019;9(JUL).
Sempere J, de Miguel S, González-Camacho F, Yuste J, Domenech M. Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of Streptococcus pneumoniae in Spain. Front Microbiol. 2020 Feb 27;11.
Phongsamart W, Srifeungfung S, Chatsuwan T, Rungnobhakhun P, Maleesatharn A, Chokephaibulkit K. Streptococcus pneumoniae Causing Invasive Diseases in Children and Adults in Central Thailand, 2012–2016. Vaccines (Basel). 2022 Aug 1;10(8).
Varon E, Cohen R, Béchet S, Doit C, Levy C. Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children. Vaccine [Internet]. 2015;33(46):6178–85. Available from: http://dx.doi.org/10.1016/j.vaccine.2020.10.015
Andrea Palacios P, Duarte C, Sanabria O, Moreno J. Molecular characterization of non-vaccine Streptococcus pneumoniae serotypes 11A, 15 B/C and 23A recovered from invasive isolates in Colombia. Biomédica. 2017;37:390–6
Daniels CC, Rogers PD, Shelton CM. A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein Antigens [Internet]. Vol. 21, J Pediatr Pharmacol Ther. 2016. Available from: www.jppt.org
Asai N, Mikamo H. Recent topics of pneumococcal vaccination: Indication of pneumococcal vaccine for individuals at a risk of pneumococcal disease in adults. Vol. 9, Microorganisms. MDPI; 2021.
Tromp KM, Campbell MW, Vazquez A. Recent Developments and Future Directions of Pneumococcal Vaccine Recommendations. Vol. 37, Clinical Therapeutics. Excerpta Medica Inc.; 2015. p. 928–34.
Lagousi T, Basdeki P, Routsias J, Spoulou V. Novel protein-based pneumococcal vaccines: Assessing the use of distinct protein fragments instead of full-length proteins as vaccine antigens. Vaccines (Basel). 2019;7(1).
Sader HS, Mendes RE, Le J, Denys G, Flamm RK, Jones RN. Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: Results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016). Open Forum Infect Dis. 2019 Mar 15;6:S14–22.
Assefa M, Tigabu A, Belachew T, Tessema B. Bacterial profile, antimicrobial susceptibility patterns, and associated factors of community-acquired pneumonia among adult patients in Gondar, Northwest Ethiopia: A cross-sectional study. PLoS One. 2022 Feb 1;17(2 February).
Temesgen D, Bereded F, Derbie A, Biadglegne F. Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot Referral Hospital, Northwest Ethiopia: A cross-sectional study. Antimicrob Resist Infect Control. 2019 Jun 14;8(1).
Yadegarynia D, Tehrani S, Nejad FM, Shojaeian F, Keyvanfar A. Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study [Internet]. Vol. 14. 2022. Available from: http://ijm.tums.ac.ir
Nagaraj S, Kalal BS, Manoharan A, Shet A. Streptococcus pneumoniae serotype prevalence and antibiotic resistance among young children with invasive pneumococcal disease: Experience from a tertiary care center in South India. Germs. 2017;7(2):78–85.
Copyright (c) 2023 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
